*$27 Million series B* generates *24% markup* on Willamette Valley Capital's 2021 investment in Elucid Biotechnologies.
Willamette Valley Capital has launched a pre-seed venture fund to back *Deep Tech* startups, leveraging our experience leading six venture funds with a *$1 Billion exit* and a *$500 Million portfolio company*.
Willamette Valley Capital has launched a pre-seed venture fund to back *Deep Tech* startups, leveraging our experience leading six venture funds with a *$1 Billion exit* and a *$500 Million portfolio company*.
